Cleopatra Hospital is trading 3.17% up at $17.90 after the August 21, 2026 session, with no clear company-specific catalyst identified.

  • No company-specific announcement, earnings release, analyst action, or regulatory event dated August 23, 2026 was found to explain the move.
  • The latest identified company disclosure was its first-quarter 2026 results, published in June.
  • Broader market context was largely unchanged.